Deciphering mechanisms and genetic modifiers in the response to FLT3 inhibition in acute myeloid leukemia - towards rational combination therapies

assignment_turned_inproject01 Oct 2019(Started)-31 Mar 2021(Ended)Closed

Funder: Swiss National Science FoundationProject code: 188110

Funded under: Careers | Fellowships | Early Postdoc.Mobility Funder Contribution: 128,150

Deciphering mechanisms and genetic modifiers in the response to FLT3 inhibition in acute myeloid leukemia - towards rational combination therapies

- Summary
- DMPs

Partners

IMP

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=snsf________::b616f5400b4e0d721e7c07f86ee60e19&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Deciphering mechanisms and genetic modifiers in the response to FLT3 inhibition in acute myeloid leukemia - towards rational combination therapies

Deciphering mechanisms and genetic modifiers in the response to FLT3 inhibition in acute myeloid leukemia - towards rational combination therapies

Loading